Eesti -
eesti -
Ravimiamet
sirdalud tablett
sandoz pharmaceuticals d.d. - tisanidiin - tablett - 2mg 30tk
Eesti -
eesti -
Ravimiamet
sirdalud tablett
sandoz pharmaceuticals d.d. - tisanidiin - tablett - 4mg 30tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
enspryng
roche registration gmbh - satralizumab - neuromyelitis optica - immunosupressandid - satralizumab (enspryng) is indicated as a monotherapy or in combination with immunosuppressive therapy (ist) for the treatment of neuromyelitis optica spectrum disorders (nmosd) in adult and adolescent patients from 12 years of age who are anti-aquaporin-4 igg (aqp4-igg) seropositive.